Home / Innere Medizin / Onkologie / Dr. Suresh Ramalingam presents the results of the FLAURA study

Dr. Suresh Ramalingam presents the results of the FLAURA study

Dr. Suresh Ramalingam presents the results of the FLAURA study (presidental symposium): Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFRm advanced NSCLC.

Cookies aktivieren

Um das Video anzusehen, müssen Sie Statistikcookies akzeptieren.

Einstellungen verwalten

 

LOGIN